as on January 23, 2026 at 4:01 pm IST
Day's Low
Day's High
1.44%
Downside
2.22%
Upside
52 Week's Low
52 Week's High
62.73%
Downside
22.27%
Upside
as on January 23, 2026 at 4:01 pm IST
Market Cap
₹63.77 Cr
Return on Equity (ROE)
0PE Ratio (TTM)
0Return on capital employed (ROCE)
0Beta (LTM)
0.37
P/B Ratio
1.07
Dividend Yield
0PEG Ratio
0Quarterly Earnings Growth YOY
-560
EPS (TTM)
0Sector
Pharmaceuticals
Book Value
0Technical Analysis
Bearish
View Technical Analysis
Compare market cap, revenue, PE, and other key metrics of Kabra Drugs with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 63.77 | 103.96% | 0.00 | -2 | NA | |
| NA | 8,956.20 | -4.8% | 0.00 | 234 | 934 | |
| NA | 620.62 | 41.44% | 0.88 | 30 | 599 | |
| NA | 45.02 | 15.17% | 0.00 | 4 | 33 | |
| BUY | 4,054.57 | -6.43% | 1.88 | -343 | 71 |
Get share price movements and forecasts by analysts on Kabra Drugs.
Source: S&P Global Market Intelligence
Search interest for Kabra Drugs Ltd Stock has decreased by -51% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Kabra Drugs.
Kabra Drugs Ltd’s net profit jumped 560% since last year same period to ₹1.84Cr in the Q2 2025-2026. On a quarterly growth basis, Kabra Drugs Ltd has generated 468% jump in its net profits since last 3-months.
Read More about Earnings ResultsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 1 Year
![]()
In the last 1 year, Kabra Drugs has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Best in 3 Years
![]()
In the last 3 years, Kabra Drugs has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Price Rise
![]()
In the last 3 months, Kabra Drugs stock has moved up by 44.3%
Retail Holding Unchanged
![]()
Retail Investor holdings remained unchanged at 100.00% of holdings in Sep 2025 quarter
| Organisation | Kabra Drugs Ltd |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Kabra Drugs share price today stands at ₹26.99 as on at the close of the market. Kabra Drugs share today touched a day high of ₹27.59 and a low of ₹26.6.
Kabra Drugs touched a 52 week high of ₹33 and a 52 week low of ₹10.06. Kabra Drugs share price today i.e. is closed at ₹26.99, which is -18.21% down from its 52 week high and 168.29% up from its 52 week low.
Kabra Drugs market capitalisation is ₹63.77 Cr as on .
To buy Kabra Drugs shares, you need to follow these steps:
Kabra Drugs trading volume is 41.47K as on . This means that 41.47K shares of Kabra Drugs were bought and sold on the stock market during today's trading session.